day 1 agenda

We are still accepting abstracts and the tentative program will be updated on March 07, 2024.
Scientific Program
     Day -1: June (20, 2024)
 Meeting Hall - 1
Registrations Open (08:00-09:00)
Opening Ceremony (09:00-09:15)
Keynote Talks
  Title: EPhotodynamic Therapy (PDT) of Tumors from Ancient Egyptians to Present: An Overview of Our Four Decades Experience
Mohamed El-Far, Mansoura University, Egypt
   
  Title: TBA
Adel K. El-Naggar, The Uni. of Texas,M.D.Anderson.org, United States
   
  Title: Tumor size>5cm is a line of demarcation of mortality and progression of gastric cancer after D2+gastrectomy for Chinese population  
Yifan Li, Shanxi Cancer Hospital, China
   
Group Photo & Refreshment Break (10:45-11:00)
Scientific Session I
  Title: TEAD Proteins Associate With DNA Repair Proteins to Facilitate Cellular Recovery From DNA Damage
Jennie R Lill, Genentech Inc., United States
   
  Title: If elevated xanthine oxidoreductase (XOR) and uric acid levels are protective during hemolysis, then are we treating tumor lysis syndrome properly
Eric E. Kelley, West Virginai University,United States
   
  Title: Evaluation of usefulness of tongue pressure measuring device for dysphagia associated with treatment of patients with head and neck cancer (ELEVATE trial)
Hirokazu Uemura, Nara Medical University, Japan
   
  Title: Real-World Utilization of Daratumumab in Front-Line Treatment of Newly Diagnosed Multiple Myeloma
Natalia Neparidze, Yale University, United States
   
  Speaker Slot Available
   
  Title: A curcumin analogue GO-Y030 depletes cancer stem cells by inhibiting the interaction between the HSP70/HSP40 complex and its substrates 
Maya Suzuki, Akita University Graduate School of Medicine, Japan
   
(13:00-14:00) Lunch Break @ Restaurant 
Scientific Session II
   
  Title: The amino acid transporter LAT1 as a molecular target for the treatment of head and neck squamous cell carcinoma
Yohei Kawasaki, Akita University Graduate School of Medicine, Japan
   
  Title: Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women
Gunnar L G Söderqvist, Karolinska Institutet, Stockholm, Sweden
   
  Title: Longitudinal analysis of T2 relaxation time variations following radiotherapy for prostate cancer
Pavla Hanzlikova, University Hospital Ostrava, Czech Republic
   
  Title: I saw the sign:  Go nuts, it’s the “acorn cyst” sign
Zhao Zhang, Mayo Clinic Florida, United States
   
  Title: Dietary Isothiocyanates: Novel Insights into the Potential for Cancer Prevention and Therapy
Yongping Bao, University of East Anglia, United Kingdom
   
  Title: Genetic variants and enzyme activity in citidin deaminase: Relationship with capecitabine toxicity and recommendation for dose adjustment
Paula Castro Sanchez, Miguel Hernandez University, Spain
   
  Speaker Slot Available
   
  Title: Targeting metabolic enzymes to suppress lung cancer progression
Ying Shen, Shanghai Jiao Tong University School of Medicine, China
   
Refreshment Break
   
  Title: Gossypol potentiates the cytotoxicity of ponatinib against human hepatocellular carcinoma HepG2 cells through cell cycle arrest and activation of p-AKT/LC3II/p62 and Bcl2/caspase-3 pathways
Naglaa Mohamed Ibrahim El-Lakkany, Theodor Bilharz Research Institute, Egypt
   
  Speaker Slot Available
   
  Title: Effect Of Melanin in Reducing Stomach Acidity, Ulceration and Possible Role for prevention of Gastric Cancer
Adila Salih El-Obeid, Ahfad University for Women, Sweden
   
Pannel Discussions
   
Please Note that this is a tentative program
Conference Hotel:
Hotel Duo,
Teplická 492, 190 00
Prag 9, Czech Republic.
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com

day 2 agenda

We are still accepting abstracts and the tentative program will be updated on March 07, 2024.
Scientific Program
     Day -2: June (21, 2024)
 Meeting Hall - 1
Scientific Session III
  Title: Zika Virus: A New oncolytic virus for cancer treatment potential. Therapeutic perspectives in Glioblastoma Treatment and implication for other tumors.
Gioacchin Iannolo, IRCCS ISMETT, Italy
   
  Title: New insights into stress signaling and metabolic rewiring of cancer cells: Mechanisms and targetable vulnerabilities
Jiri Bartek, Dansh Cancer Institute, Denmark
   
  Title: Empowering Cancer Research: The Evolution of Local data Commons in the Era of Next-Generation Sequencing and Artificial Intelligence
Jong Cheol Jeong, University of Kentucky, United States
   
  Speaker Slot Available
   
  Title: TBA
Mojgan Najafzadeh, University of Bradford, United Kingdom
   
  Title: Digital image analysis of microscopy images as a diagnostic tool for cancer
Sirish Karri, Ariel University, Israel
   
  Title: Loss of the fructose transporter SLC2A5 inhibits cancer cell migration
Jody Groenendyk, University of Alberta, Canada
   
  Title: A novel Approach for Patient Treatment Planning of Localized Cancer
Pradyumna Ghosh, IITBHU, India
   
(13:00-14:00) Lunch Break @ Restaurant 
Scientific Session IV
   
  Title: Role of wnt-pathway and dkk-3 expression in glioblastoma: correlations with biomolecular markers
Maria Caffo, University of Messina, Italy
   
  Title: Anti-tumor B cells interact with cancer stem cells and exosomal PD-L1
Qiao Li, University of Michigan, United states
   
  Speaker Slot Available
   
  Title: Casein kinase 2 inhibitor, CX-4945, induces apoptosis and restore blood brain barrier homeostasis altered in glioblastoma
Alessia Filippone, University of Messina, Italy
   
  Title: Diagnostic significance of serum p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma
Sharmistha Dey, All India Institute of Medical Science, India
   
  Title: Feasibility of prolyl oligopeptidase (PREP) as tumor biomarker in glioblastoma patients: a pilot study
Giovanna Casili, University of Messina, Italy
   
  Title: A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cance
Jianping Chen, The University of Hong Kong, Hong Kong
   
  Speaker Slot Available
   
Refreshment Break
   
  Title: Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma
Nabieh Ayoub, Technion - Israel Institute of Technology, Israel
   
  Title: Analysis of Cervix Intraepithelial Neoplasia Prevalence in the Kurdistan Region, Iraq
Fatima Kamal Khalid, University of Zakho,college of Medicine, Iraq
   
  Speaker Slot Available
   
Pannel Discussions
   
Please Note that this is a tentative program
Conference Hotel:
Hotel Duo,
Teplická 492, 190 00
Prag 9, Czech Republic.
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com

day 3 agenda

We are still accepting abstracts and the tentative program will be updated on March 07, 2024.
Scientific Program
     Day -3: June (22, 2024)
 Meeting Hall - 1
Scientific Session V
   
  Title: The development of a novel personalized chimeric antigen receptors macrophage therapy targeting metastatic triple-negative breast cancer expressing the cancer testis antigen MAGE-A
Anton Dormer, PepVax, Inc., United states
   
  Title: Inhaled Exosomes Genetically Manipulated to Overexpress CD24 (EXO-CD24) as a Compassionate Use in Severe ARDS Patients
Ian Michelson, Sackler School of Medicine at Tel Aviv University, Israel
   
  Title: Potential role of vacuumassisted procedures in resecting breast cancers and highlighting selection criteria to support future trials
Carolina Nazareth Valadares, Universidade Federal de Minas Gerais, Brazil
   
  Title: Sustained release of anti-cancer drug from biomimetic calcium phosphate bone substitute
Yuelian Liu, ACTA, Netherlands
   
  Speaker Slot Available
   
  Title: Tissue-Based Biomarkers of Response to Immunotherapy
Julie Stein Deutsch, Johns Hopkins University, United states
   
  Speaker Slot Available
   
Pannel Discussions
   
(13:00-14:00) Lunch Break @ Restaurant 
   
Closing Ceremony
Please Note that this is a tentative program
Conference Hotel:
Hotel Duo,
Teplická 492, 190 00
Prag 9, Czech Republic.
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com

Virtual Agenda

Scientific Program
Virtual Presentations through ZOOM
Time Zone: CET
  Title: The epigenetic reader ENL controls oncogenic transcription driven by super-enhancer and represents a synergistic vulnerability for BET inhibition
Xing-sheng Shu, Shenzhen University, China
   
  Title: Physicochemical and Functional Similarity Assessment between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
Cuihua Liu, Bio-Thera Solutions Ltd, China
   
  Speaker Slot Available
   
  Title: PD-L1 expression and prognosis in definitive radiotherapy patients with Neuroendocrine cervical carcinoma
Huiling Li, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, China
   
  Speaker Slot Available
   
  Title: Association of SOX2, OCT 4 and WNT5A expression in Dysplstic Leukoplakia and Oral Squamous cell carcinoma
Anjali Narwal, Post Graduate Institute of Dental Sciences, India
   
  Speaker Slot Available
   
  Title: TBA
Thomas Vogl, Frankfurt University Hospital, Germany
   
  Title: Optimisation of selenium in reduction of cancer risk and all-cause mortality
Jan Lubinski, Pomeranian Medical University, Poland
   
  Speaker Slot Available
   
  Title: Comprehensive spatially defined transcriptomic and proteomic characterization of human and canine myxo- and fibrosarcoma and their adjacent peritumoral tissue
Enni Markkanen, University of Zurich, Switzerland
   
  Speaker Slot Available
   
  Title: Spermidine can protect against oral squamous cell carcinoma induced by 4- nitroquinoline 1-oxide in a mouse model
Andreia Machado Leopoldino, University of São Paulo, Brazil
   
  Title: Dietary phytochemicals and Chinese nutritional herbs as potential drug candidates for breast cancer
Nitin T Telang, Palindrome Liaisons Consultants, United States
   
  Speaker Slot Available
   
  Title: Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma
Terry Moody, National Cancer Institute, United States
   
  Title: Integrated variant allele frequency analysis pipeline and R package: easyVAF 
Dexiang Gao, University of Colorado Anschutz Medical Campus, United States
   
  Speaker Slot Available
   
  Title: Tissue-Based Biomarkers of Response to Immunotherapy
Julie Stein Deutsch, Johns Hopkins University, United States
   
  Speaker Slot Available
Closing Ceremony
Conference Hotel:
Hotel Duo,
Teplická 492, 190 00
Prag 9, Czech Republic.
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com

Download